newsfilter
← Latest News
GlobeNewswire·

Corvus Pharmaceuticals Appoints David Moore to Board of Directors

SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US